Free Trial

Agilysys (AGYS) Financials

Agilysys logo
$69.86 +2.52 (+3.73%)
As of 12:41 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Agilysys

Annual Income Statements for Agilysys

This table shows Agilysys' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-11 -3.77 -12 -8.05 -13 -34 -24 4.64 13 85 23
Consolidated Net Income / (Loss)
-11 -3.77 -12 -8.35 -13 -34 -21 6.48 15 86 23
Net Income / (Loss) Continuing Operations
-11 -3.77 -12 -8.05 -13 -34 -21 6.48 15 86 23
Total Pre-Tax Income
-13 -3.76 -11 -12 -13 -34 -21 6.51 16 21 26
Total Operating Income
-12 -4.31 -11 -12 -13 -34 -21 6.32 13 16 23
Total Gross Profit
60 68 64 64 74 81 89 102 121 144 172
Total Revenue
104 120 128 127 141 161 137 163 198 237 276
Operating Revenue
104 120 128 127 141 161 137 163 198 237 276
Total Cost of Revenue
43 52 64 63 67 80 48 61 77 93 104
Operating Cost of Revenue
43 52 64 63 67 80 48 61 77 93 104
Total Operating Expenses
73 72 75 76 87 115 110 95 108 129 149
Selling, General & Admin Expense
22 22 20 24 23 24 36 29 31 36 41
Marketing Expense
16 20 21 18 20 20 14 15 23 28 33
Research & Development Expense
25 27 29 28 38 41 55 46 50 57 62
Depreciation Expense
2.23 2.20 2.41 2.63 2.50 2.57 2.83 2.21 1.77 3.90 3.68
Amortization Expense
3.46 1.24 1.39 1.88 2.57 2.54 1.96 1.65 1.74 1.37 3.86
Other Operating Expenses / (Income)
- - - - 1.17 0.58 - - 0.44 1.76 4.63
Other Special Charges / (Income)
1.69 0.45 0.09 0.15 0.14 -0.13 0.20 0.97 0.35 0.03 0.84
Total Other Income / (Expense), net
-0.08 0.55 -0.08 0.48 0.14 0.20 -0.25 0.19 2.89 4.93 3.04
Interest Expense
0.05 0.03 0.02 0.01 0.01 0.01 0.02 0.01 0.00 0.00 1.53
Interest & Investment Income
0.11 0.09 0.16 0.10 0.34 0.38 0.11 0.06 2.19 5.08 3.78
Other Income / (Expense), net
-0.15 0.49 -0.22 0.39 -0.19 -0.18 -0.34 0.15 0.70 -0.15 0.79
Income Tax Expense
-1.05 0.01 0.24 -3.25 0.22 0.20 -0.21 0.03 1.18 -66 2.41
Preferred Stock Dividends Declared
- - - - 0.00 0.00 2.61 1.84 1.84 1.20 0.00
Basic Earnings per Share
($0.51) ($0.17) ($0.52) ($0.37) ($0.57) ($1.47) ($1.01) $0.19 $0.52 $3.31 $0.84
Weighted Average Basic Shares Outstanding
22.34M 22.48M 22.62M 22.80M 23.04M 23.23M 23.46M 24.36M 24.69M 25.67M 27.52M
Diluted Earnings per Share
($0.51) ($0.17) ($0.52) ($0.37) ($0.57) ($1.47) ($1.01) $0.18 $0.49 $3.17 $0.82
Weighted Average Diluted Shares Outstanding
22.34M 22.48M 22.62M 22.80M 23.04M 23.23M 23.46M 25.48M 25.93M 26.84M 28.26M
Weighted Average Basic & Diluted Shares Outstanding
22.34M 22.48M 22.62M 22.80M 23.04M 23.40M 23.89M 24.74M 25.34M 27.45M 28.02M

Quarterly Income Statements for Agilysys

This table shows Agilysys' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1.09 4.09 77 66 14 1.36 3.83 - 4.89 12 9.90
Consolidated Net Income / (Loss)
1.55 4.55 77 67 14 1.36 3.83 - 4.89 12 9.90
Net Income / (Loss) Continuing Operations
1.55 4.55 77 67 14 1.36 3.83 - 4.89 12 9.90
Total Pre-Tax Income
1.90 4.84 9.10 0.42 7.37 5.15 7.74 - 4.85 16 13
Total Operating Income
0.96 3.56 7.75 -1.53 5.75 4.13 7.41 - 4.52 14 12
Total Gross Profit
33 35 38 17 40 43 44 - 47 49 50
Total Revenue
56 59 61 36 64 68 70 - 77 79 80
Operating Revenue
56 59 61 36 64 68 70 - 77 79 80
Total Cost of Revenue
23 24 23 19 24 25 26 - 29 30 30
Operating Cost of Revenue
23 24 23 19 24 25 26 - 29 30 30
Total Operating Expenses
32 32 30 19 34 39 36 - 43 35 39
Selling, General & Admin Expense
10 9.00 9.06 3.51 10 10 9.54 - 11 10 11
Marketing Expense
7.30 6.40 6.14 3.62 7.01 8.79 9.01 - 12 9.78 9.11
Research & Development Expense
13 15 15 11 15 16 15 - 17 18 19
Depreciation Expense
0.92 1.21 0.91 1.16 0.84 0.92 0.99 - 0.94 0.96 1.01
Amortization Expense
0.43 0.35 0.34 -1.41 0.25 0.90 1.62 - 1.46 1.43 1.42
Other Operating Expenses / (Income)
- - -0.92 - 0.55 2.04 -0.01 - 0.26 -5.46 -2.72
Other Special Charges / (Income)
- - 0.00 -0.67 0.27 0.10 0.33 - 0.11 0.11 -0.06
Total Other Income / (Expense), net
0.94 1.28 1.35 1.95 1.63 1.02 0.33 - 0.33 1.56 1.15
Interest Expense
0.00 0.00 0.00 -1.12 0.00 0.46 0.66 - 0.22 0.06 0.03
Interest & Investment Income
1.10 1.23 1.25 1.79 1.78 1.10 0.42 - 0.45 0.35 0.49
Other Income / (Expense), net
-0.16 0.05 0.10 -0.95 -0.16 0.38 0.57 - 0.10 1.27 0.70
Income Tax Expense
0.35 0.30 -68 -66 -6.73 3.78 3.91 - -0.04 4.00 2.99
Basic Earnings per Share
$0.04 $0.16 $2.98 $2.60 $0.52 $0.05 $0.14 - $0.18 $0.42 $0.35
Weighted Average Basic Shares Outstanding
24.94M 25.02M 25.81M 25.67M 27.13M 27.53M 27.67M 27.52M 27.79M 27.88M 27.97M
Diluted Earnings per Share
$0.04 $0.16 $2.85 $2.48 $0.50 $0.05 $0.14 - $0.17 $0.41 $0.35
Weighted Average Diluted Shares Outstanding
26.18M 26.12M 26.98M 26.84M 28.13M 28.26M 28.31M 28.26M 28.29M 28.40M 28.44M
Weighted Average Basic & Diluted Shares Outstanding
25.35M 25.37M 27.36M 27.45M 27.88M 27.95M 27.96M 28.02M 28.04M 28.04M 28.11M

Annual Cash Flow Statements for Agilysys

This table details how cash moves in and out of Agilysys' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Net Change in Cash & Equivalents
-24 -14 -11 -9.51 0.94 5.88 53 -2.21 16 32 -72
Net Cash From Operating Activities
-2.19 7.22 3.43 6.87 7.24 11 28 28 34 48 55
Net Cash From Continuing Operating Activities
-2.19 7.22 3.43 6.87 7.24 11 28 28 34 48 55
Net Income / (Loss) Continuing Operations
-11 -3.77 -12 -8.35 -13 -34 -21 6.48 15 86 23
Consolidated Net Income / (Loss)
-11 -3.77 -12 -8.35 -13 -34 -21 6.48 15 86 23
Depreciation Expense
2.23 2.20 2.41 2.63 2.50 2.57 2.83 2.21 1.77 3.90 3.68
Amortization Expense
4.76 2.27 9.40 12 15 15 1.96 1.65 1.90 1.53 4.32
Non-Cash Adjustments To Reconcile Net Income
5.20 3.73 2.17 4.69 4.39 29 40 15 13 13 18
Changes in Operating Assets and Liabilities, net
-2.87 2.79 1.17 -3.99 -1.66 -1.97 4.48 3.39 3.19 -56 6.10
Net Cash From Investing Activities
-22 -21 -14 -15 -5.53 -3.45 -1.39 -26 -6.87 -7.60 -149
Net Cash From Continuing Investing Activities
-22 -21 -14 -15 -5.53 -3.45 -1.39 -26 -6.87 -7.60 -149
Purchase of Property, Plant & Equipment
-4.65 -5.90 -4.16 -6.14 - -3.42 -1.39 -1.20 -7.24 -8.13 -2.78
Acquisitions
-3.75 - 0.00 - - 0.00 0.00 -24 0.40 0.00 -146
Sale of Property, Plant & Equipment
- - - - 3.32 - - 0.00 0.00 0.55 0.00
Other Investing Activities, net
-14 -15 -9.71 -8.95 2.22 -0.03 -0.00 -0.03 -0.03 -0.03 -0.03
Net Cash From Financing Activities
-0.40 -0.58 -0.45 -1.30 -0.77 -1.12 25 -4.90 -11 -8.56 22
Net Cash From Continuing Financing Activities
-0.40 -0.58 -0.85 -1.30 -0.77 -1.12 25 -4.90 -11 -8.56 22
Repayment of Debt
-0.14 -0.14 -0.12 -0.12 -0.12 -0.02 -0.02 -0.02 -0.00 -0.00 -26
Payment of Dividends
- - - - 0.00 0.00 -1.12 -1.84 -1.84 -1.66 0.00
Issuance of Debt
- - - - - - - - 0.00 0.00 50
Issuance of Common Equity
- - - - - - - - 0.00 0.00 1.03
Other Financing Activities, net
-0.26 -0.44 -0.73 -1.17 -0.65 -1.09 -7.51 -3.05 -9.25 -6.89 -2.74
Effect of Exchange Rate Changes
-0.28 -0.09 -0.07 - - -0.13 0.20 -0.10 - 0.02 -0.34

Quarterly Cash Flow Statements for Agilysys

This table details how cash moves in and out of Agilysys' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2024 12/31/2024 3/31/2024 6/30/2024 9/30/2025 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents
-5.75 -89 5.87 116 -0.78 -13 5.87 12 -17 3.77 22
Net Cash From Operating Activities
0.02 6.59 20 20 1.10 9.77 20 27 -4.35 15 23
Net Cash From Continuing Operating Activities
0.02 6.59 20 20 1.10 9.77 20 27 -4.35 15 23
Net Income / (Loss) Continuing Operations
1.55 1.36 3.83 67 14 2.49 3.83 3.93 4.89 12 9.90
Consolidated Net Income / (Loss)
1.55 1.36 3.83 67 14 2.49 3.83 3.93 4.89 12 9.90
Depreciation Expense
0.92 0.91 0.99 1.16 0.84 1.07 0.99 0.94 0.94 0.96 1.01
Amortization Expense
0.43 0.90 1.62 -1.25 0.25 2.97 1.62 1.24 1.62 1.60 1.58
Non-Cash Adjustments To Reconcile Net Income
3.17 4.03 4.22 0.29 4.43 5.60 4.22 5.12 5.03 5.00 5.77
Changes in Operating Assets and Liabilities, net
-6.05 -0.62 9.63 -47 -19 -2.37 9.63 16 -17 -4.06 5.04
Net Cash From Investing Activities
-3.07 -146 -0.59 139 -0.87 0.02 -0.59 -1.51 -0.63 -0.22 -0.57
Net Cash From Continuing Investing Activities
-3.07 -146 -0.59 139 -0.87 0.02 -0.59 -1.51 -0.63 -0.22 -0.57
Purchase of Property, Plant & Equipment
-3.07 -0.65 -0.56 -6.05 -0.87 0.02 -0.56 -0.70 -0.63 -0.22 -0.57
Net Cash From Financing Activities
-2.70 50 -13 -44 -0.93 -23 -13 -13 -13 -11 -0.62
Net Cash From Continuing Financing Activities
-2.70 50 -13 -44 -0.93 -23 -13 -13 -13 -11 -0.62
Other Financing Activities, net
-1.78 -0.50 -1.42 -4.05 -0.93 0.18 -1.42 0.11 -0.92 0.18 -0.62
Effect of Exchange Rate Changes
-0.00 0.18 -0.40 0.33 -0.08 0.33 -0.40 -0.04 0.43 -0.18 0.01

Annual Balance Sheets for Agilysys

This table presents Agilysys' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Total Assets
182 185 167 157 164 155 190 214 243 350 434
Total Current Assets
105 96 74 64 79 93 133 136 155 189 124
Cash & Equivalents
75 61 49 40 41 47 99 97 113 145 73
Accounts Receivable
25 22 16 16 27 36 26 25 22 29 32
Inventories, net
0.64 2.69 2.21 2.00 2.04 3.89 1.18 6.94 9.77 4.59 5.17
Prepaid Expenses
3.83 10 6.46 5.59 6.27 4.87 4.80 5.42 7.42 7.73 9.26
Other Current Assets
- - - 0.00 2.92 2.13 2.36 1.67 2.24 2.29 4.52
Plant, Property, & Equipment, net
12 15 16 18 16 12 8.79 6.35 15 18 17
Total Noncurrent Assets
65 74 78 76 69 49 48 72 74 144 294
Goodwill
20 20 20 20 20 20 20 33 33 33 131
Intangible Assets
41 52 56 54 43 8.40 8.40 20 18 17 71
Noncurrent Deferred & Refundable Income Taxes
- - - - 0.44 0.76 1.80 2.66 2.79 67 67
Other Noncurrent Operating Assets
4.13 3.05 2.63 2.48 5.68 20 18 16 20 26 26
Total Liabilities & Shareholders' Equity
182 185 167 157 164 155 190 214 243 350 434
Total Liabilities
57 62 54 49 63 83 110 117 134 114 168
Total Current Liabilities
51 54 46 45 58 69 61 71 79 89 111
Accounts Payable
17 7.76 8.70 8.40 4.72 13 6.35 9.77 9.42 9.42 12
Accrued Expenses
10 13 8.33 9.24 14 9.03 11 11 14 20 22
Other Current Liabilities
- - - 27 39 47 43 51 55 60 76
Total Noncurrent Liabilities
6.73 7.58 7.30 4.20 5.15 13 49 45 55 25 57
Long-Term Debt
- - - - - - - - - 0.00 24
Noncurrent Deferred & Payable Income Tax Liabilities
3.05 3.08 3.18 0.23 0.86 0.88 0.92 0.94 2.26 0.55 11
Other Noncurrent Operating Liabilities
3.63 4.29 4.00 3.91 4.26 12 48 44 53 24 22
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
124 123 114 108 101 72 80 97 109 236 266
Total Preferred & Common Equity
124 123 114 108 101 72 80 97 109 236 266
Preferred Stock
- - - - - 0.00 - - 0.00 0.00 0.00
Total Common Equity
124 123 114 108 101 72 80 97 109 236 266
Common Stock
-1.19 1.84 3.70 7.57 10 15 47 59 62 105 120
Retained Earnings
128 124 113 104 93 59 35 40 53 138 161
Treasury Stock
-2.65 -2.60 -2.52 -2.49 -2.43 -2.40 -2.28 -2.06 -1.88 -1.79 -1.60
Accumulated Other Comprehensive Income / (Loss)
-0.15 -0.18 -0.20 -0.26 -0.26 0.20 0.04 -0.06 -4.03 -4.17 -13

Quarterly Balance Sheets for Agilysys

This table presents Agilysys' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 6/30/2023 9/30/2023 12/31/2023 6/30/2024 9/30/2024 12/31/2024 6/30/2025 9/30/2025 12/31/2025
Total Assets
255 347 251 255 347 356 442 444 426 426 475
Total Current Assets
153 184 149 153 184 187 109 131 109 118 170
Cash & Equivalents
107 116 107 107 116 144 55 61 56 59 81
Accounts Receivable
28 49 26 28 49 27 32 49 35 37 64
Inventories, net
7.49 6.77 8.45 7.49 6.77 5.30 6.45 6.36 6.62 7.71 7.79
Prepaid Expenses
7.47 9.39 6.03 7.47 9.39 6.52 11 11 7.47 10 13
Other Current Assets
3.28 1.97 2.28 3.28 1.97 3.52 4.54 4.02 3.81 4.05 3.42
Plant, Property, & Equipment, net
17 18 16 17 18 18 18 17 16 15 15
Total Noncurrent Assets
84 145 86 84 145 151 316 296 301 292 291
Goodwill
33 33 33 33 33 33 135 129 136 134 136
Intangible Assets
18 17 18 18 17 17 79 74 72 70 69
Noncurrent Deferred & Refundable Income Taxes
3.15 68 2.93 3.15 68 76 75 68 67 63 61
Other Noncurrent Operating Assets
31 27 32 31 27 26 26 26 26 26 26
Total Liabilities & Shareholders' Equity
255 347 251 255 347 356 442 444 426 426 475
Total Liabilities
139 116 140 139 116 102 182 187 143 129 162
Total Current Liabilities
73 91 74 73 91 77 96 115 98 97 130
Accounts Payable
10 9.01 11 10 9.01 10 13 12 14 13 13
Accrued Expenses
14 15 11 14 15 13 22 17 12 16 19
Other Current Liabilities
49 67 52 49 67 54 61 86 71 68 98
Total Noncurrent Liabilities
66 25 66 66 25 24 86 72 45 32 32
Long-Term Debt
- - - - - - 50 38 12 0.00 0.00
Noncurrent Deferred & Payable Income Tax Liabilities
2.28 1.04 2.30 2.28 1.04 0.55 12 12 12 11 12
Other Noncurrent Operating Liabilities
64 24 63 64 24 24 24 23 22 21 21
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
117 230 112 117 230 254 260 257 283 297 313
Total Preferred & Common Equity
117 230 112 117 230 254 260 257 283 297 313
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
117 230 112 117 230 254 260 257 283 297 313
Common Stock
65 101 63 65 101 108 112 115 125 131 136
Retained Earnings
58 135 54 58 135 152 153 157 166 178 187
Treasury Stock
-1.87 -1.80 -1.88 -1.87 -1.80 -1.64 -1.62 -1.62 -1.60 -1.59 -1.58
Accumulated Other Comprehensive Income / (Loss)
-4.09 -3.90 -3.51 -4.09 -3.90 -4.33 -3.62 -14 -6.06 -10 -8.50

Annual Metrics And Ratios for Agilysys

This table displays calculated financial ratios and metrics derived from Agilysys' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
2.22% 16.28% 6.07% -0.25% 10.59% 14.14% -14.67% 18.56% 21.78% 19.89% 16.07%
EBITDA Growth
-262.10% 111.40% -71.81% 1,467.40% 55.13% -476.30% 0.34% 162.58% 65.41% 22.12% 49.28%
EBIT Growth
-136.86% 69.70% -204.34% -0.49% -13.54% -157.96% 37.80% 130.35% 109.96% 14.95% 49.88%
NOPAT Growth
-101.47% 65.40% -164.50% -5.89% -8.29% -160.39% 38.47% 142.85% 89.43% 451.20% -68.82%
Net Income Growth
-167.25% 67.25% -211.31% 28.76% -57.65% -158.79% 38.35% 130.85% 125.10% 491.11% -73.06%
EPS Growth
-166.23% 66.67% -205.88% 28.85% -54.05% -157.89% 31.29% 117.82% 172.22% 546.94% -74.13%
Operating Cash Flow Growth
-3,094.52% 430.19% -52.44% 100.23% 5.34% 46.04% 168.62% 0.24% 21.03% 39.82% 14.41%
Free Cash Flow Firm Growth
-31.21% 30.78% 43.97% -31.81% 96.97% 2,989.67% 172.64% -144.99% 218.16% -286.33% -255.57%
Invested Capital Growth
46.57% 28.12% 2.33% 6.21% -12.79% -58.04% -176.80% 101.94% -1,041.87% 2,693.04% 136.77%
Revenue Q/Q Growth
0.93% 2.75% -1.03% 1.16% -7.30% 13.16% -2.37% -4.91% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
-563,200.00% 118.84% -90.51% 385.41% -17.85% -344.70% 19.79% 169.58% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
-43.04% 52.68% -50.05% 21.89% -13.76% -216.16% 9.53% 138.28% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
-32.68% 45.81% -40.10% 19.87% -13.08% -213.03% 9.37% 152.21% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
-42.31% 50.81% -47.05% 37.81% -34.53% -219.46% 11.43% 140.18% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% -44.44% 36.21% -29.55% -219.57% 9.82% 122.78% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-216.59% 33.39% -70.74% 4,881.16% 11.49% -2.04% 50.33% -12.37% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
-3.15% -79.30% 22.55% 22.39% 91.67% 141.50% -40.12% 53.77% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-10.16% 7.56% -0.92% -2.96% -10.88% -54.36% -78.37% -93.85% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
58.04% 56.58% 49.96% 50.58% 52.46% 50.36% 65.15% 62.43% 61.00% 60.75% 62.40%
EBITDA Margin
-5.44% 0.53% 0.14% 2.23% 3.12% -10.30% -12.03% 6.35% 8.63% 8.79% 11.39%
Operating Margin
-12.04% -3.58% -8.94% -9.48% -9.29% -21.19% -15.28% 3.89% 6.50% 6.63% 8.20%
EBIT Margin
-12.18% -3.18% -9.11% -9.18% -9.42% -21.30% -15.52% 3.97% 6.85% 6.57% 8.48%
Profit (Net Income) Margin
-11.11% -3.13% -9.18% -6.56% -9.35% -21.19% -15.31% 3.98% 7.36% 36.30% 8.43%
Tax Burden Percent
91.60% 100.16% 102.05% 71.98% 101.71% 100.59% 99.02% 99.49% 92.50% 416.72% 90.60%
Interest Burden Percent
99.51% 98.35% 98.74% 99.25% 97.52% 98.92% 99.59% 100.73% 116.15% 132.58% 109.64%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.51% 7.50% -316.72% 9.40%
Return on Invested Capital (ROIC)
-21.04% -5.37% -12.49% -12.69% -14.25% -56.09% -503.19% 0.00% 0.00% 149.10% 13.27%
ROIC Less NNEP Spread (ROIC-NNEP)
-17.86% -4.26% -5.66% -12.92% -4.29% -32.68% -494.51% 0.00% 0.00% 133.16% 10.43%
Return on Net Nonoperating Assets (RNNOA)
12.10% 2.33% 2.61% 5.17% 1.65% 16.56% 475.49% 0.00% 0.00% -99.25% -4.03%
Return on Equity (ROE)
-8.95% -3.04% -9.89% -7.52% -12.59% -39.53% -27.70% 7.31% 14.11% 49.85% 9.25%
Cash Return on Invested Capital (CROIC)
-58.82% -30.02% -14.80% -18.71% -0.59% 25.68% 0.00% -3,569.61% 0.00% -32.18% -67.95%
Operating Return on Assets (OROA)
-6.77% -2.08% -6.60% -7.20% -8.27% -21.52% -12.37% 3.20% 5.94% 5.26% 5.96%
Return on Assets (ROA)
-6.17% -2.05% -6.65% -5.15% -8.21% -21.42% -12.19% 3.21% 6.38% 29.05% 5.92%
Return on Common Equity (ROCE)
-8.95% -3.04% -9.89% -7.52% -12.59% -39.53% -27.70% 7.31% 14.11% 49.85% 9.25%
Return on Equity Simple (ROE_SIMPLE)
-9.26% -3.05% -10.31% -7.70% -13.08% -47.48% -26.29% 6.65% 13.34% 36.45% 8.73%
Net Operating Profit after Tax (NOPAT)
-8.73 -3.02 -7.99 -8.46 -9.16 -24 -15 6.29 12 66 20
NOPAT Margin
-8.43% -2.51% -6.25% -6.64% -6.50% -14.83% -10.69% 3.87% 6.01% 27.64% 7.43%
Net Nonoperating Expense Percent (NNEP)
-3.18% -1.10% -6.83% 0.24% -9.96% -23.41% -8.68% 0.19% 2.55% 15.95% 2.84%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 7.06%
Cost of Revenue to Revenue
41.96% 43.42% 50.04% 49.42% 47.54% 49.64% 34.85% 37.57% 39.00% 39.25% 37.60%
SG&A Expenses to Revenue
20.93% 18.13% 15.57% 18.87% 16.41% 15.16% 26.10% 18.03% 15.70% 16.02% 14.81%
R&D to Revenue
24.46% 22.17% 22.75% 21.93% 26.85% 25.79% 40.35% 28.49% 25.38% 23.89% 22.64%
Operating Expenses to Revenue
70.09% 60.17% 58.89% 59.83% 61.74% 71.54% 80.43% 58.54% 54.50% 54.11% 54.20%
Earnings before Interest and Taxes (EBIT)
-13 -3.82 -12 -12 -13 -34 -21 6.46 14 16 23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-5.63 0.64 0.18 2.84 4.40 -17 -17 10 17 21 31
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.81 1.90 1.93 2.56 4.95 5.51 14.19 10.13 19.03 9.04 7.63
Price to Tangible Book Value (P/TBV)
3.52 4.50 5.70 7.91 13.11 9.03 21.86 22.19 35.54 11.45 31.48
Price to Revenue (P/Rev)
2.17 1.95 1.72 2.18 3.54 2.46 8.26 6.06 10.50 9.00 7.36
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 212.32 163.19 25.16 87.34
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.47% 0.61% 3.98% 1.14%
Enterprise Value to Invested Capital (EV/IC)
3.04 2.76 2.64 3.47 7.64 13.87 0.00 2,369.70 0.00 21.76 9.13
Enterprise Value to Revenue (EV/Rev)
1.45 1.45 1.34 1.87 3.25 2.17 7.54 5.46 9.93 8.39 7.18
Enterprise Value to EBITDA (EV/EBITDA)
0.00 271.48 941.95 83.94 103.95 0.00 0.00 86.04 115.14 95.53 63.08
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 137.48 144.94 127.75 84.66
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 141.35 165.17 30.36 96.71
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 24.15 49.66 34.64 63.18 32.95 36.42 31.21 57.08 41.36 35.91
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 31.93 34.77 0.00 124.37 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09
Financial Leverage
-0.68 -0.55 -0.46 -0.40 -0.39 -0.51 -0.96 -1.11 -1.02 -0.75 -0.39
Leverage Ratio
1.45 1.48 1.49 1.46 1.53 1.85 2.27 2.28 2.21 1.72 1.56
Compound Leverage Factor
1.44 1.46 1.47 1.45 1.50 1.83 2.26 2.30 2.57 2.28 1.71
Debt to Total Capital
0.15% 0.27% 0.21% 0.16% 0.03% 0.03% 0.01% 0.00% 0.00% 0.00% 8.28%
Short-Term Debt to Total Capital
0.11% 0.10% 0.11% 0.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.04% 0.17% 0.10% 0.05% 0.03% 0.03% 0.01% 0.00% 0.00% 0.00% 8.28%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
99.85% 99.73% 99.79% 99.84% 99.97% 99.97% 99.99% 100.00% 100.00% 100.00% 91.72%
Debt to EBITDA
-0.03 0.52 1.31 0.06 0.01 0.00 0.00 0.00 0.00 0.00 0.76
Net Debt to EBITDA
13.29 -93.89 -270.82 -14.02 -9.26 2.82 6.01 -9.39 0.00 0.00 -1.56
Long-Term Debt to EBITDA
-0.01 0.33 0.64 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.76
Debt to NOPAT
-0.02 -0.11 -0.03 -0.02 0.00 0.00 0.00 0.00 0.00 0.00 1.17
Net Debt to NOPAT
8.58 19.96 6.14 4.70 4.45 1.96 6.76 -15.42 0.00 0.00 -2.40
Long-Term Debt to NOPAT
-0.01 -0.07 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 1.17
Altman Z-Score
4.04 4.07 4.13 5.05 6.29 3.89 7.25 6.55 11.01 12.97 8.59
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.08 1.77 1.59 1.43 1.37 1.35 2.18 1.91 1.97 2.11 1.11
Quick Ratio
1.99 1.53 1.40 1.26 1.17 1.19 2.04 1.71 1.72 1.95 0.94
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-24 -17 -9.46 -12 -0.38 11 30 -13 16 -29 -105
Operating Cash Flow to CapEx
-47.01% 122.34% 82.56% 111.95% 0.00% 309.21% 2,045.14% 2,378.86% 476.14% 636.12% 1,980.88%
Free Cash Flow to Firm to Interest Expense
-508.23 -582.24 -630.71 -1,247.00 -37.77 1,212.70 1,487.82 -1,115.50 0.00 0.00 -68.54
Operating Cash Flow to Interest Expense
-45.54 248.90 228.87 687.40 724.10 1,175.00 1,420.35 2,372.92 0.00 0.00 36.05
Operating Cash Flow Less CapEx to Interest Expense
-142.42 45.45 -48.33 73.40 1,055.90 795.00 1,350.90 2,273.17 0.00 0.00 34.23
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.56 0.66 0.72 0.78 0.88 1.01 0.80 0.81 0.87 0.80 0.70
Accounts Receivable Turnover
4.22 5.07 6.79 7.96 6.49 5.11 4.45 6.39 8.33 9.17 9.04
Inventory Turnover
77.42 31.36 26.06 29.90 33.12 26.91 18.88 15.06 9.24 12.98 21.23
Fixed Asset Turnover
8.56 8.86 8.17 7.60 8.45 11.45 13.05 21.49 18.93 14.61 15.91
Accounts Payable Turnover
3.14 4.29 7.76 7.36 10.21 8.81 4.84 7.58 8.05 9.89 9.50
Days Sales Outstanding (DSO)
86.56 72.02 53.77 45.84 56.22 71.37 81.95 57.12 43.82 39.82 40.37
Days Inventory Outstanding (DIO)
4.71 11.64 14.00 12.21 11.02 13.56 19.33 24.24 39.49 28.12 17.19
Days Payable Outstanding (DPO)
116.22 85.02 47.02 49.59 35.75 41.44 75.40 48.12 45.32 36.89 38.41
Cash Conversion Cycle (CCC)
-24.95 -1.37 20.75 8.46 31.49 43.50 25.89 33.25 37.98 31.06 19.15
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
49 63 65 69 60 25 -19 0.38 -3.53 92 217
Invested Capital Turnover
2.50 2.14 2.00 1.91 2.19 3.78 47.05 -17.19 -125.48 5.39 1.79
Increase / (Decrease) in Invested Capital
16 14 1.48 4.01 -8.78 -35 -44 20 -3.91 95 125
Enterprise Value (EV)
150 174 170 238 458 348 1,034 889 1,967 1,993 1,979
Market Capitalization
225 235 220 278 498 395 1,134 986 2,080 2,138 2,029
Book Value per Share
$5.44 $5.37 $4.89 $4.65 $4.28 $3.03 $3.38 $3.94 $4.34 $9.21 $9.51
Tangible Book Value per Share
$2.79 $2.27 $1.66 $1.51 $1.61 $1.85 $2.19 $1.80 $2.32 $7.28 $2.30
Total Capital
124 124 114 109 101 72 80 97 109 236 290
Total Debt
0.19 0.33 0.24 0.18 0.04 0.03 0.01 0.00 0.00 0.00 24
Total Long-Term Debt
0.05 0.22 0.12 0.06 0.04 0.03 0.01 0.00 0.00 0.00 24
Net Debt
-75 -60 -49 -40 -41 -47 -99 -97 -113 -145 -49
Capital Expenditures (CapEx)
4.65 5.90 4.16 6.14 -3.32 3.42 1.39 1.20 7.24 7.58 2.78
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-21 -19 -22 -20 -20 -23 -27 -32 -37 -45 -61
Debt-free Net Working Capital (DFNWC)
55 42 27 19 21 24 72 65 76 100 13
Net Working Capital (NWC)
54 41 27 19 21 24 72 65 76 100 13
Net Nonoperating Expense (NNE)
2.77 0.75 3.74 -0.11 4.01 10 6.33 -0.19 -2.67 -21 -2.76
Net Nonoperating Obligations (NNO)
-75 -60 -49 -40 -41 -47 -99 -97 -113 -145 -49
Total Depreciation and Amortization (D&A)
6.98 4.46 12 15 18 18 4.79 3.86 3.51 5.26 8.00
Debt-free, Cash-free Net Working Capital to Revenue
-19.82% -15.86% -17.19% -16.08% -13.90% -14.10% -19.74% -19.84% -18.53% -19.09% -21.96%
Debt-free Net Working Capital to Revenue
52.70% 34.49% 21.39% 15.28% 15.05% 14.92% 52.56% 39.79% 38.44% 41.93% 4.54%
Net Working Capital to Revenue
52.56% 34.40% 21.29% 15.19% 15.05% 14.92% 52.56% 39.79% 38.44% 41.93% 4.54%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.51) ($0.17) ($0.52) ($0.37) ($0.57) ($1.47) ($1.01) $0.19 $0.52 $3.31 $0.84
Adjusted Weighted Average Basic Shares Outstanding
22.77M 22.94M 23.21M 23.23M 23.50M 23.23M 23.46M 24.36M 24.69M 25.67M 27.52M
Adjusted Diluted Earnings per Share
($0.51) ($0.17) ($0.52) ($0.37) ($0.57) ($1.47) ($1.01) $0.18 $0.49 $3.17 $0.82
Adjusted Weighted Average Diluted Shares Outstanding
22.77M 22.94M 23.21M 23.23M 23.50M 23.40M 23.89M 25.48M 25.93M 26.84M 28.26M
Adjusted Basic & Diluted Earnings per Share
($0.51) ($0.17) ($0.52) ($0.37) ($0.57) ($1.47) ($1.01) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
22.34M 22.48M 22.62M 22.80M 23.04M 23.40M 23.89M 24.74M 25.34M 27.45M 28.02M
Normalized Net Operating Profit after Tax (NOPAT)
-6.26 -2.51 -6.83 -7.09 -9.06 -7.31 -15 7.25 12 11 21
Normalized NOPAT Margin
-6.05% -2.08% -5.35% -5.57% -6.43% -4.55% -10.59% 4.46% 6.18% 4.65% 7.70%
Pre Tax Income Margin
-12.12% -3.12% -9.00% -9.11% -9.19% -21.07% -15.46% 4.00% 7.96% 8.71% 9.30%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-262.77 -131.79 -775.47 -1,168.90 -1,327.20 -3,804.11 -1,064.80 538.67 0.00 0.00 15.29
NOPAT to Interest Expense
-181.81 -104.11 -532.37 -845.60 -915.67 -2,649.19 -733.53 523.91 0.00 0.00 13.39
EBIT Less CapEx to Interest Expense
-359.65 -335.24 -1,052.67 -1,782.90 -995.40 -4,184.11 -1,134.25 438.92 0.00 0.00 13.47
NOPAT Less CapEx to Interest Expense
-278.69 -307.56 -809.57 -1,459.60 -583.87 -3,029.19 -802.98 424.16 0.00 0.00 11.57
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -5.32% 28.34% 12.59% 1.93% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -5.32% 28.34% 12.59% 1.93% 0.00%

Quarterly Metrics And Ratios for Agilysys

This table displays calculated financial ratios and metrics derived from Agilysys' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2024 9/30/2024 12/31/2024 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
DEI Shares Outstanding
- - - - - - - 27,963,988.00 - 28,042,795.00 28,042,508.00
DEI Adjusted Shares Outstanding
- - - - - - - 27,963,988.00 - 28,042,795.00 28,042,508.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - 0.00 - 0.42 0.35
Growth Metrics
- - - - - - - - - - -
Revenue Growth
13.29% 16.49% 14.85% 58.22% 0.00% 0.00% 0.00% 0.00% 0.00% 16.14% 15.57%
EBITDA Growth
210.36% 22.40% 16.41% -413.00% 0.00% 35.15% 0.00% -52.56% 0.00% 184.21% 39.66%
EBIT Growth
599.62% 24.80% 1.76% -288.89% 0.00% 0.00% 0.00% -100.00% 0.00% 242.00% 55.66%
NOPAT Growth
1,308.89% -67.30% -94.42% -57,328.15% 0.00% 0.00% 0.00% -100.00% 0.00% 864.15% 145.90%
Net Income Growth
811.24% -69.99% -95.04% 197.44% 0.00% 0.00% 0.00% 0.00% 0.00% 758.50% 158.41%
EPS Growth
1,150.00% -68.75% -95.09% 196.88% 0.00% 0.00% 0.00% 0.00% 0.00% 720.00% 150.00%
Operating Cash Flow Growth
4,890.91% 20.96% 57.16% 25.65% 0.00% 48.24% 0.00% -8.91% 0.00% 0.00% 14.82%
Free Cash Flow Firm Growth
-3,779.44% -5,500.64% -420.78% -7,885.09% 111.64% 107.78% 101.59% -34.70% 103.65% 111.63% 109.78%
Invested Capital Growth
2,296.26% 2,674.30% 0.00% 2,693.04% 0.00% -7.03% 0.00% 136.77% 0.00% -7.03% -1.01%
Revenue Q/Q Growth
0.00% 7.51% 1.88% -48.09% 75.88% 7.51% 1.88% 0.00% 0.00% 3.42% 1.38%
EBITDA Q/Q Growth
0.00% -5.27% 67.41% -124.32% 359.28% 28.03% 67.38% -79.70% 0.00% 150.28% -16.49%
EBIT Q/Q Growth
0.00% -19.34% 77.07% -131.09% 325.22% -19.34% 77.07% -100.00% 0.00% 233.86% -19.41%
NOPAT Q/Q Growth
0.00% -90.05% 235.15% -6,701.41% 104.54% -90.05% 235.15% -100.00% 0.00% 131.27% -14.52%
Net Income Q/Q Growth
0.00% -90.33% 180.79% 1,646.61% -78.91% -90.33% 180.79% 0.00% 0.00% 139.47% -15.48%
EPS Q/Q Growth
0.00% -90.00% 180.00% 1,671.43% -79.84% -90.00% 180.00% 0.00% 0.00% 141.18% -14.63%
Operating Cash Flow Q/Q Growth
0.00% 500.18% 207.86% -0.38% 0.00% 789.71% 0.00% 33.83% 0.00% 450.05% 53.13%
Free Cash Flow Firm Q/Q Growth
0.00% -159.42% 6.00% -46.32% 103.26% 73.30% 235.15% -7.71% 0.00% 122.80% -60.11%
Invested Capital Q/Q Growth
0.00% 132.03% -8.36% -60.87% 20.17% 115.71% -8.36% -7.34% 0.00% -0.94% -2.42%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
62.77% 63.29% 63.05% 47.96% 62.77% 63.29% 63.05% 0.00% 61.68% 61.75% 62.50%
EBITDA Margin
10.52% 9.27% 15.23% -7.13% 10.52% 12.52% 15.23% 0.00% 9.37% 22.68% 18.68%
Operating Margin
9.05% 6.04% 10.65% -4.24% 9.05% 6.04% 10.65% 0.00% 5.90% 17.84% 14.59%
EBIT Margin
8.80% 6.60% 11.48% -6.87% 8.80% 6.60% 11.48% 0.00% 6.02% 19.45% 15.46%
Profit (Net Income) Margin
22.21% 2.00% 5.51% 185.24% 22.21% 2.00% 5.51% 0.00% 6.38% 14.77% 12.31%
Tax Burden Percent
191.35% 26.51% 49.46% 15,814.42% 191.35% 26.51% 49.46% 0.00% 100.85% 74.53% 76.82%
Interest Burden Percent
131.88% 114.13% 96.98% -17.04% 131.88% 114.13% 96.98% 0.00% 104.98% 101.88% 103.66%
Effective Tax Rate
-91.35% 73.49% 50.54% -15,714.42% -91.35% 73.49% 50.54% 0.00% -0.85% 25.47% 23.18%
Return on Invested Capital (ROIC)
62.07% 2.61% 10.09% -3,613.86% 39.43% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
59.60% 2.12% 8.65% -3,853.54% 37.27% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-40.92% -0.63% -0.77% 2,872.24% -21.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
21.15% 1.97% 9.33% -741.62% 18.30% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)
-144.60% -170.76% -237.37% -32.18% -61.80% 0.00% 0.00% -67.95% 0.00% 7.29% 1.01%
Operating Return on Assets (OROA)
5.96% 4.08% 5.80% -5.50% 6.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
15.04% 1.23% 2.78% 148.24% 15.65% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
21.15% 1.97% 9.33% -741.62% 18.30% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)
10.68% 9.21% -19.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
11 1.09 3.67 -242 11 1.09 3.67 0.00 4.56 11 9.01
NOPAT Margin
17.31% 1.60% 5.27% -670.03% 17.31% 1.60% 5.27% 0.00% 5.95% 13.30% 11.21%
Net Nonoperating Expense Percent (NNEP)
2.48% 0.48% 1.45% 239.67% 2.16% 0.84% 0.72% 0.00% 0.76% 3.63% 1.70%
Return On Investment Capital (ROIC_SIMPLE)
- - 1.24% -102.32% 4.33% 0.37% 1.24% 0.00% 1.54% 3.55% 2.88%
Cost of Revenue to Revenue
37.23% 36.71% 36.95% 52.04% 37.23% 36.71% 36.95% 0.00% 38.32% 38.25% 37.50%
SG&A Expenses to Revenue
17.37% 17.87% 13.71% 9.72% 16.51% 14.88% 13.71% 0.00% 14.03% 12.82% 13.48%
R&D to Revenue
23.18% 23.69% 21.52% 30.12% 23.18% 23.69% 21.52% 0.00% 22.76% 22.48% 23.54%
Operating Expenses to Revenue
53.72% 57.25% 52.39% 52.20% 53.72% 57.25% 52.39% 0.00% 55.78% 43.91% 47.90%
Earnings before Interest and Taxes (EBIT)
5.59 4.51 7.98 -2.48 5.59 4.51 7.98 0.00 4.62 15 12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
6.68 6.33 11 -2.58 6.68 8.55 11 2.18 7.19 18 15
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
11.25 11.67 14.34 9.04 11.25 10.24 14.34 7.63 11.34 9.95 10.64
Price to Tangible Book Value (P/TBV)
13.96 66.31 67.29 11.45 13.96 32.63 67.29 31.48 42.76 31.70 30.72
Price to Revenue (P/Rev)
13.91 14.12 16.42 9.00 11.41 0.00 0.00 7.36 0.00 0.00 0.00
Price to Earnings (P/E)
110.98 131.86 0.00 25.16 37.73 0.00 0.00 87.34 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.90% 0.76% 0.00% 3.98% 2.65% 0.00% 0.00% 1.14% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
24.67 11.88 15.63 21.76 24.67 12.55 15.63 9.13 13.22 12.18 14.03
Enterprise Value to Revenue (EV/Rev)
13.21 14.10 16.32 8.39 10.83 0.00 0.00 7.18 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
125.63 133.22 150.80 94.81 126.11 0.00 0.00 63.08 0.00 286.78 0.00
Enterprise Value to EBIT (EV/EBIT)
147.85 157.51 188.62 127.75 185.58 0.00 0.00 84.66 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
120.26 149.63 0.00 30.36 44.09 0.00 0.00 96.71 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
76.39 82.70 83.04 41.36 63.52 0.00 0.00 35.91 0.00 49.60 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 161.01 1,377.59
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.19 0.15 0.00 0.00 0.00 0.15 0.09 0.04 0.00 0.00
Long-Term Debt to Equity
0.00 0.19 0.15 0.00 0.00 0.00 0.15 0.09 0.04 0.00 0.00
Financial Leverage
-0.69 -0.30 -0.09 -0.75 -0.57 -0.20 -0.09 -0.39 -0.16 -0.12 -0.18
Leverage Ratio
1.66 1.85 1.73 1.72 1.40 1.43 1.73 1.56 1.45 1.56 1.61
Compound Leverage Factor
2.19 2.11 1.68 -0.29 1.85 1.64 1.68 0.00 1.53 1.59 1.67
Debt to Total Capital
0.00% 16.12% 12.89% 0.00% 0.00% 0.00% 12.89% 8.28% 4.06% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 16.12% 12.89% 0.00% 0.00% 0.00% 12.89% 8.28% 4.06% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 83.88% 87.11% 100.00% 100.00% 100.00% 87.11% 91.72% 95.94% 100.00% 100.00%
Debt to EBITDA
0.00 2.20 1.57 0.00 0.00 0.00 0.00 0.76 0.00 0.00 0.00
Net Debt to EBITDA
0.00 -0.21 -0.94 0.00 0.00 0.00 0.00 -1.56 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 2.20 1.57 0.00 0.00 0.00 0.00 0.76 0.00 0.00 0.00
Debt to NOPAT
0.00 2.47 -0.87 0.00 0.00 0.00 0.00 1.17 0.00 0.00 0.00
Net Debt to NOPAT
0.00 -0.24 0.52 0.00 0.00 0.00 0.00 -2.40 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 2.47 -0.87 0.00 0.00 0.00 0.00 1.17 0.00 0.00 0.00
Altman Z-Score
18.49 11.07 12.91 12.80 18.62 0.00 0.00 8.41 14.10 14.51 13.08
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.41 1.13 1.14 2.11 2.41 1.22 1.14 1.11 1.11 1.22 1.31
Quick Ratio
2.21 0.90 0.96 1.95 2.21 0.99 0.96 0.94 0.93 0.99 1.12
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-94 -245 -230 -337 11 19 3.67 -125 4.56 29 11
Operating Cash Flow to CapEx
126.35% 1,012.29% 3,609.96% 334.33% 0.00% 0.00% 3,609.96% 3,873.32% -686.57% 7,010.60% 4,058.36%
Free Cash Flow to Firm to Interest Expense
0.00 -535.10 -350.63 0.00 0.00 41.61 5.58 0.00 21.01 509.06 379.09
Operating Cash Flow to Interest Expense
0.00 14.39 30.88 0.00 0.00 21.33 30.88 0.00 -20.03 271.66 776.50
Operating Cash Flow Less CapEx to Interest Expense
0.00 12.97 30.02 0.00 0.00 21.37 30.02 0.00 -22.94 267.79 757.37
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.68 0.62 0.51 0.80 0.70 0.00 0.00 0.70 0.00 0.00 0.00
Accounts Receivable Turnover
7.77 7.25 4.55 9.17 9.18 0.00 0.00 9.04 0.00 0.00 0.00
Inventory Turnover
11.33 11.40 12.96 12.98 18.67 0.00 0.00 21.23 0.00 0.00 0.00
Fixed Asset Turnover
12.22 12.29 13.29 14.61 14.19 0.00 0.00 15.91 0.00 0.00 0.00
Accounts Payable Turnover
7.55 6.96 7.05 9.89 9.81 0.00 0.00 9.50 0.00 0.00 0.00
Days Sales Outstanding (DSO)
46.97 50.36 80.23 39.82 39.77 0.00 0.00 40.37 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
32.22 32.01 28.17 28.12 19.55 0.00 0.00 17.19 0.00 0.00 0.00
Days Payable Outstanding (DPO)
48.34 52.42 51.76 36.89 37.20 0.00 0.00 38.41 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
30.85 29.95 56.64 31.06 22.12 0.00 0.00 19.15 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
110 255 234 92 110 237 234 217 240 237 232
Invested Capital Turnover
3.59 1.63 1.92 5.39 2.28 0.00 0.00 1.79 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
105 246 234 95 0.00 -18 0.00 125 0.00 -18 -2.36
Enterprise Value (EV)
2,715 3,033 3,659 1,993 2,715 2,979 3,659 1,979 3,168 2,892 3,251
Market Capitalization
2,859 3,038 3,681 2,138 2,859 3,038 3,681 2,029 3,212 2,952 3,333
Book Value per Share
$9.26 $9.33 $9.19 $9.21 $9.26 $10.64 $9.19 $9.51 $10.11 $10.58 $11.17
Tangible Book Value per Share
$7.46 $1.64 $1.96 $7.28 $7.46 $3.34 $1.96 $2.30 $2.68 $3.32 $3.87
Total Capital
254 310 295 236 254 297 295 290 295 297 313
Total Debt
0.00 50 38 0.00 0.00 0.00 38 24 12 0.00 0.00
Total Long-Term Debt
0.00 50 38 0.00 0.00 0.00 38 24 12 0.00 0.00
Net Debt
-144 -4.89 -23 -145 -144 -59 -23 -49 -44 -59 -81
Capital Expenditures (CapEx)
0.87 0.65 0.56 6.05 0.00 -0.02 0.56 0.70 0.63 0.22 0.57
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-35 -42 -45 -45 -35 -38 -45 -61 -45 -38 -42
Debt-free Net Working Capital (DFNWC)
109 13 16 100 109 21 16 13 11 21 40
Net Working Capital (NWC)
109 13 16 100 109 21 16 13 11 21 40
Net Nonoperating Expense (NNE)
-3.11 -0.27 -0.16 -309 -3.11 -0.27 -0.16 0.00 -0.33 -1.17 -0.88
Net Nonoperating Obligations (NNO)
-144 -4.89 -23 -145 -144 -59 -23 -49 -44 -59 -81
Total Depreciation and Amortization (D&A)
1.09 1.82 2.61 -0.09 1.09 4.04 2.61 2.18 2.57 2.56 2.59
Debt-free, Cash-free Net Working Capital to Revenue
-16.91% -19.55% -19.85% -19.09% -13.87% 0.00% 0.00% -21.96% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
53.21% 5.95% 7.25% 41.93% 43.64% 0.00% 0.00% 4.54% 0.00% 0.00% 0.00%
Net Working Capital to Revenue
53.21% 5.95% 7.25% 41.93% 43.64% 0.00% 0.00% 4.54% 0.00% 0.00% 0.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.52 $0.05 $0.14 $2.60 $0.52 $0.05 $0.14 $0.00 $0.18 $0.42 $0.35
Adjusted Weighted Average Basic Shares Outstanding
27.13M 27.53M 27.67M 25.67M 27.13M 27.53M 27.67M 27.52M 27.79M 27.88M 27.97M
Adjusted Diluted Earnings per Share
$0.50 $0.05 $0.14 $2.48 $0.50 $0.05 $0.14 $0.00 $0.17 $0.41 $0.35
Adjusted Weighted Average Diluted Shares Outstanding
28.13M 28.26M 28.31M 26.84M 28.13M 28.26M 28.31M 28.26M 28.29M 28.40M 28.44M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
27.88M 27.95M 27.96M 27.45M 27.88M 28.04M 27.96M 28.02M 28.04M 28.04M 28.11M
Normalized Net Operating Profit after Tax (NOPAT)
4.21 2.96 5.42 -1.54 4.21 2.96 5.42 0.00 3.24 11 8.96
Normalized NOPAT Margin
6.63% 4.34% 7.79% -4.27% 6.63% 4.34% 7.79% 0.00% 4.23% 13.40% 11.15%
Pre Tax Income Margin
11.61% 7.54% 11.13% 1.17% 11.61% 7.54% 11.13% 0.00% 6.32% 19.81% 16.03%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 9.85 12.15 0.00 0.00 9.85 12.15 0.00 21.29 275.38 414.27
NOPAT to Interest Expense
0.00 2.39 5.58 0.00 0.00 2.39 5.58 0.00 21.01 188.29 300.43
EBIT Less CapEx to Interest Expense
0.00 8.42 11.30 0.00 0.00 9.89 11.30 0.00 18.37 271.50 395.13
NOPAT Less CapEx to Interest Expense
0.00 0.97 4.72 0.00 0.00 2.43 4.72 0.00 18.09 184.42 281.29
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
3.38% 3.83% -0.35% 1.93% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
3.38% 3.83% -0.35% 1.93% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Here are the key trends for AGILYSYS (AGYS) over the last four years, focusing on cash flow, income, and balance sheet dynamics. The bullets highlight what may positively or negatively impact the stock for retail investors.

  • Revenue growth: Q1 2026 total revenue reached $76.7 million, up from $63.5 million in Q1 2025 and generally higher than many prior quarters, indicating a recovering top line.
  • Net income turning positive: Q1 2026 net income / loss attributable to common shareholders was $4.89 million, marking a return to quarterly profitability after losses in late 2024 and earlier years.
  • Operating cash flow remains strong in recent quarters: Q3 2025 cash from continuing operating activities was about $20.3 million and Q4 2024 was about $20.2 million, supporting liquidity and ongoing flexibility.
  • Long-term debt fully paid off: LT debt was zero by Q3 2025 and has remained so, reducing interest expense and leverage risk.
  • Acquisition activity: Q4 2024 included acquisitions totaling about $145 million, which boosted noncurrent assets and growth potential but temporarily pressured cash flow.
  • Intangible assets and goodwill are sizable: Goodwill around $128–136 million and intangible assets around $68–73 million, reflecting prior acquisitions and potential future impairment and amortization considerations.
  • Significant current liabilities: Total current liabilities ranged from roughly $97 million to $130 million across 2024–2025, indicating ongoing working capital needs.
  • Net change in cash in Q1 2026: a net decrease of about $17.5 million, despite positive earnings, signaling near-term cash burn and sensitivity to working capital changes.
  • Financing cash flows remain a drag in several periods: net cash from financing activities has been negative in multiple quarters (e.g., mid-2025 onward), reflecting debt repayments and financing outflows rather than new inflows.
05/18/26 11:30 AM ETAI Generated. May Contain Errors.

Agilysys Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Agilysys' financial year ends in March. Their financial year 2025 ended on March 31, 2025.

Agilysys' net income appears to be on an upward trend, with a most recent value of $23.23 million in 2025, falling from -$11.50 million in 2015. The previous period was $86.20 million in 2024. Find out what analysts predict for Agilysys in the coming months.

Agilysys' total operating income in 2025 was $22.59 million, based on the following breakdown:
  • Total Gross Profit: $171.99 million
  • Total Operating Expenses: $149.40 million

Over the last 10 years, Agilysys' total revenue changed from $103.51 million in 2015 to $275.62 million in 2025, a change of 166.3%.

Agilysys' total liabilities were at $168.48 million at the end of 2025, a 47.9% increase from 2024, and a 193.8% increase since 2015.

In the past 10 years, Agilysys' cash and equivalents has ranged from $39.94 million in 2018 to $144.89 million in 2024, and is currently $73.04 million as of their latest financial filing in 2025.

Over the last 10 years, Agilysys' book value per share changed from 5.44 in 2015 to 9.51 in 2025, a change of 74.7%.



Financial statements for NASDAQ:AGYS last updated on 3/29/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners